Does EVEROLIMUS Cause Disease progression? 1,246 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,246 reports of Disease progression have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 3.1% of all adverse event reports for EVEROLIMUS.
1,246
Reports of Disease progression with EVEROLIMUS
3.1%
of all EVEROLIMUS reports
194
Deaths
143
Hospitalizations
How Dangerous Is Disease progression From EVEROLIMUS?
Of the 1,246 reports, 194 (15.6%) resulted in death, 143 (11.5%) required hospitalization, and 14 (1.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which EVEROLIMUS Alternatives Have Lower Disease progression Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE